An update on the role of intestinal cytochrome P450 enzymes in drug disposition

Fang Xie, Xinxin Ding, Qing Yu Zhang

Research output: Contribution to journalReview article

36 Citations (Scopus)

Abstract

Oral administration is the most commonly used route for drug treatment. Intestinal cytochrome P450 (CYP)-mediated metabolism can eliminate a large proportion of some orally administered drugs before they reach systemic circulation, while leaving the passage of other drugs unimpeded. A better understanding of the ability of intestinal P450 enzymes to metabolize various clinical drugs in both humans and preclinical animal species, including the identification of the CYP enzymes expressed, their regulation, and the relative importance of intestinal metabolism compared to hepatic metabolism, is important for improving bioavailability of current drugs and new drugs in development. Here, we briefly review the expression of drug-metabolizing P450 enzymes in the small intestine of humans and several preclinical animal species, and provide an update of the various factors or events that regulate intestinal P450 expression, including a cross talk between the liver and the intestine. We further compare various clinical and preclinical approaches for assessing the impact of intestinal drug metabolism on bioavailability, and discuss the utility of the intestinal epithelium-specific NADPH-cytochrome P450 reductase-null (IECN) mouse as a useful model for studying in vivo roles of intestinal P450 in the disposition of orally administered drugs.

Original languageEnglish (US)
Pages (from-to)374-383
Number of pages10
JournalActa Pharmaceutica Sinica B
Volume6
Issue number5
DOIs
StatePublished - Sep 1 2016
Externally publishedYes

Fingerprint

Cytochrome P-450 Enzyme System
Pharmaceutical Preparations
Biological Availability
NADPH-Ferrihemoprotein Reductase
Liver
Intestinal Mucosa
Small Intestine
Intestines
Oral Administration

Keywords

  • Bioavailability
  • Cytochrome P450
  • Drug disposition
  • Drug metabolism
  • Intestine

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

An update on the role of intestinal cytochrome P450 enzymes in drug disposition. / Xie, Fang; Ding, Xinxin; Zhang, Qing Yu.

In: Acta Pharmaceutica Sinica B, Vol. 6, No. 5, 01.09.2016, p. 374-383.

Research output: Contribution to journalReview article

@article{f0f0d0bec2a745168f4064c542ec4407,
title = "An update on the role of intestinal cytochrome P450 enzymes in drug disposition",
abstract = "Oral administration is the most commonly used route for drug treatment. Intestinal cytochrome P450 (CYP)-mediated metabolism can eliminate a large proportion of some orally administered drugs before they reach systemic circulation, while leaving the passage of other drugs unimpeded. A better understanding of the ability of intestinal P450 enzymes to metabolize various clinical drugs in both humans and preclinical animal species, including the identification of the CYP enzymes expressed, their regulation, and the relative importance of intestinal metabolism compared to hepatic metabolism, is important for improving bioavailability of current drugs and new drugs in development. Here, we briefly review the expression of drug-metabolizing P450 enzymes in the small intestine of humans and several preclinical animal species, and provide an update of the various factors or events that regulate intestinal P450 expression, including a cross talk between the liver and the intestine. We further compare various clinical and preclinical approaches for assessing the impact of intestinal drug metabolism on bioavailability, and discuss the utility of the intestinal epithelium-specific NADPH-cytochrome P450 reductase-null (IECN) mouse as a useful model for studying in vivo roles of intestinal P450 in the disposition of orally administered drugs.",
keywords = "Bioavailability, Cytochrome P450, Drug disposition, Drug metabolism, Intestine",
author = "Fang Xie and Xinxin Ding and Zhang, {Qing Yu}",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.apsb.2016.07.012",
language = "English (US)",
volume = "6",
pages = "374--383",
journal = "Acta Pharmaceutica Sinica B",
issn = "2211-3835",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - An update on the role of intestinal cytochrome P450 enzymes in drug disposition

AU - Xie, Fang

AU - Ding, Xinxin

AU - Zhang, Qing Yu

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Oral administration is the most commonly used route for drug treatment. Intestinal cytochrome P450 (CYP)-mediated metabolism can eliminate a large proportion of some orally administered drugs before they reach systemic circulation, while leaving the passage of other drugs unimpeded. A better understanding of the ability of intestinal P450 enzymes to metabolize various clinical drugs in both humans and preclinical animal species, including the identification of the CYP enzymes expressed, their regulation, and the relative importance of intestinal metabolism compared to hepatic metabolism, is important for improving bioavailability of current drugs and new drugs in development. Here, we briefly review the expression of drug-metabolizing P450 enzymes in the small intestine of humans and several preclinical animal species, and provide an update of the various factors or events that regulate intestinal P450 expression, including a cross talk between the liver and the intestine. We further compare various clinical and preclinical approaches for assessing the impact of intestinal drug metabolism on bioavailability, and discuss the utility of the intestinal epithelium-specific NADPH-cytochrome P450 reductase-null (IECN) mouse as a useful model for studying in vivo roles of intestinal P450 in the disposition of orally administered drugs.

AB - Oral administration is the most commonly used route for drug treatment. Intestinal cytochrome P450 (CYP)-mediated metabolism can eliminate a large proportion of some orally administered drugs before they reach systemic circulation, while leaving the passage of other drugs unimpeded. A better understanding of the ability of intestinal P450 enzymes to metabolize various clinical drugs in both humans and preclinical animal species, including the identification of the CYP enzymes expressed, their regulation, and the relative importance of intestinal metabolism compared to hepatic metabolism, is important for improving bioavailability of current drugs and new drugs in development. Here, we briefly review the expression of drug-metabolizing P450 enzymes in the small intestine of humans and several preclinical animal species, and provide an update of the various factors or events that regulate intestinal P450 expression, including a cross talk between the liver and the intestine. We further compare various clinical and preclinical approaches for assessing the impact of intestinal drug metabolism on bioavailability, and discuss the utility of the intestinal epithelium-specific NADPH-cytochrome P450 reductase-null (IECN) mouse as a useful model for studying in vivo roles of intestinal P450 in the disposition of orally administered drugs.

KW - Bioavailability

KW - Cytochrome P450

KW - Drug disposition

KW - Drug metabolism

KW - Intestine

UR - http://www.scopus.com/inward/record.url?scp=84995427062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995427062&partnerID=8YFLogxK

U2 - 10.1016/j.apsb.2016.07.012

DO - 10.1016/j.apsb.2016.07.012

M3 - Review article

AN - SCOPUS:84995427062

VL - 6

SP - 374

EP - 383

JO - Acta Pharmaceutica Sinica B

JF - Acta Pharmaceutica Sinica B

SN - 2211-3835

IS - 5

ER -